HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity.

Abstract
Focal segmental glomerulosclerosis (FSGS) is associated with circulating permeability activity (Palb) and recurs after transplantation in about 30% of patients. The FS permeability factor (FSPF) consists of anionic low-molecular-weight protein(s) that might be excluded by the anionic filtration barrier. We postulated that FSPF may interact with sugars of the glycocalyx, and we tested its affinity for sugars using column chromatography. FSPF showed high affinity for galactose; Palb activity was absent from unbound material and present in eluate after dialysis to remove galactose. In parallel studies, Palb activity of serum was lost after adding galactose > or = 10(-12) M. To determine whether galactose also abolishes plasma Palb activity in vivo, a patient with posttransplant FSGS was given galactose and serum samples were collected. Intravenous infusion of galactose decreased Palb from 0.88 before infusion to undetectable levels postinfusion and at 48 hours. Oral galactose diminished Palb activity; Palb reached a nadir after 2 weeks and remained low for at least 4 weeks after galactose was discontinued. We conclude that FSPF has high affinity for galactose based on chromatography. Additionally, galactose inactivates FSPF and may lead to its clearance from plasma. The interaction between FSPF and glomeruli may depend on FSPF binding to galactose, and the FSPF-galactose complex may be susceptible to uptake by galactose-binding proteins and to catabolism. We propose testing galactose as a novel nontoxic therapy for nephrotic syndrome in FSGS to determine whether galactose slows progression and whether pretransplant therapy decreases rates of recurrence and graft loss.
AuthorsVirginia J Savin, Ellen T McCarthy, Ram Sharma, Deane Charba, Mukut Sharma
JournalTranslational research : the journal of laboratory and clinical medicine (Transl Res) Vol. 151 Issue 6 Pg. 288-92 (Jun 2008) ISSN: 1931-5244 [Print] United States
PMID18514139 (Publication Type: Journal Article)
Chemical References
  • Biological Factors
  • Proteins
  • Galactose
Topics
  • Biological Factors (metabolism)
  • Chromatography, Affinity
  • Dialysis
  • Galactose (administration & dosage, metabolism, pharmacology)
  • Glomerulosclerosis, Focal Segmental (blood, metabolism)
  • Humans
  • Kidney Transplantation
  • Permeability (drug effects)
  • Plasmapheresis
  • Proteins (metabolism)
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: